|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.275 0.000 (0.000%) | 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 26,769 | 41.650% | 18,898 | 18,844 | 15,025 | 11,730 |
| Cost of Sales | (21,450) | 73.012% | (12,398) | (15,723) | (11,986) | (9,137) |
| Gross Profit | 5,319 | -18.169% | 6,500 | 3,121 | 3,039 | 2,593 |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (531) | 3,247 | |
| Profit / (Loss) before Taxation | (3,679) | -17.474% | (4,458) | (2,239) | 15,769 | (13,377) | |
| Taxation | (119) | -- | 10 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 117 | -- | (1,065) | (637) | (361) | (126) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (3,681) | -33.231% | (5,513) | (2,876) | 15,408 | (13,503) | |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | 2,139 | -36.716% | 3,380 | 1,875 | 4,001 | 9,068 |
| Depreciation & Amortisation | 341 | -6.061% | 363 | 240 | 692 | 668 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.580 | -73.272% | -2.170 | -1.570 | 8.460 | -7.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.065) | -- | (0.022) | (0.960) | (0.815) | (0.665218) |
| Remarks: | Real time quote last updated: 05/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -3,681 |
| %Change | -33.231% |
| EPS / (LPS) | HKD -0.006 |
| NBV Per Share ($) | HKD -0.065 |